A Phase I Pharmacokinetic Study of HMN-214, a Novel Oral Stilbene Derivative With Polo-Like Kinase-1-Interacting Properties, in Patients With Advanced Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-0214
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2006
Authors
Publisher
American Association for Cancer Research (AACR)